-
1
-
-
0026763156
-
Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment
-
Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992; 58: 249-61.
-
(1992)
Fertil Steril
, vol.58
, pp. 249-261
-
-
Navot, D.1
Bergh, P.A.2
Laufer, N.3
-
2
-
-
84881351128
-
-
Ovulation Induction: European Practice in Gynaecology and Obstetrics Series; Tarlatzis BC Ed. Amsterdam: Elsevier
-
Pellicer A, Garcia-Velasco J. Ovarian hyperstimulation syndrome. In: Ovulation Induction: European Practice in Gynaecology and Obstetrics Series; Tarlatzis BC Ed. Amsterdam: Elsevier. 2003; pp. 249-67.
-
(2003)
Ovarian Hyperstimulation Syndrome
, pp. 249-267
-
-
Pellicer, A.1
Garcia-Velasco, J.2
-
3
-
-
0034002055
-
Distinction between early and late ovarian hyperstimulation syndrome
-
Mathur RS, Akande AV, Keay SD, et al. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000; 73: 901-97.
-
(2000)
Fertil Steril
, vol.73
, pp. 901-997
-
-
Mathur, R.S.1
Akande, A.V.2
Keay, S.D.3
-
4
-
-
0038423919
-
The Ovarian Reninangiotensin System (OVRAS): A Possible Role In the Pathogenesis of the Ovarian Hyperstimulation Syndrome
-
Pellicer A, Simón C, Bonilla-Musoles F et al., Eds. Serono Symposia Publications
-
Palumbo A, Montes De Oca MJ, et al. The ovarian reninangiotensin system (OVRAS): a possible role in the pathogenesis of the ovarian hyperstimulation syndrome. In: Ovarian hyperstimulation syndrome: pathophysiology, prevention and treatment; Pellicer A, Simón C, Bonilla-Musoles F et al., Eds. Serono Symposia Publications, 1999; pp.17-29.
-
(1999)
Ovarian hyperstimulation syndrome: Pathophysiology, prevention and treatment
, pp. 17-29
-
-
Palumbo, A.1
Montes De Oca, M.J.2
-
5
-
-
0025806420
-
In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17, 20-desmolase deficiency
-
Pellicer A, Miro F, Sampaio M, et al. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17, 20-desmolase deficiency. Fertil Steril 1991; 55: 970-5.
-
(1991)
Fertil Steril
, vol.55
, pp. 970-975
-
-
Pellicer, A.1
Miro, F.2
Sampaio, M.3
-
6
-
-
9244223621
-
Expression of endothelin-1 gene and protein in human granulosa cells
-
Magini A, Granchi S, Orlando C, et al. Expression of endothelin-1 gene and protein in human granulosa cells. J Clin Endocrinol Metab 1996; 81: 1428-33.
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 1428-1433
-
-
Magini, A.1
Granchi, S.2
Orlando, C.3
-
7
-
-
0028814949
-
Increased capillary induced by human follicular fluid: A hypothesis for an ovarian origin of the hyperstimulation syndrome
-
Goldsman MP, Pedram A, Dominguez CE, et al. Increased capillary induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fert Steril 1995; 63: 268-72.
-
(1995)
Fert Steril
, vol.63
, pp. 268-272
-
-
Goldsman, M.P.1
Pedram, A.2
Dominguez, C.E.3
-
8
-
-
0036259602
-
The role of endothelium in the patogénesis of ovarian hyperstimulation síndrome
-
Albert C, Garrido N, Mercader A, et al. The role of endothelium in the patogénesis of ovarian hyperstimulation síndrome. Mol Hum Reprod 2002; 8: 409-18.
-
(2002)
Mol Hum Reprod
, vol.8
, pp. 409-418
-
-
Albert, C.1
Garrido, N.2
Mercader, A.3
-
9
-
-
34250723951
-
Review of evidence base strategies to prevente ovarian hyperstimulation syndrome
-
Mathur R, Kailasam C, Jenkins J. Review of evidence base strategies to prevente ovarian hyperstimulation syndrome. Hum Fertil (Camb) 2007; 10: 75-85.
-
(2007)
Hum Fertil (Camb)
, vol.10
, pp. 75-85
-
-
Mathur, R.1
Kailasam, C.2
Jenkins, J.3
-
10
-
-
0037837014
-
Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF recpetor-2 expression that is associated to vascular hyperpermeability
-
Gómez R, Simón C, Remohí J, et al. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF recpetor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 2003; 68: 2164-71.
-
(2003)
Biol Reprod
, vol.68
, pp. 2164-2171
-
-
Gómez, R.1
Simón, C.2
Remohí, J.3
-
11
-
-
0036827816
-
Vascular endotelial growth factor receptor-2 activation induces vascular permeability in hyperstimulation rats, and this effect is prevented by receptor blockade
-
Gómez R, Simón C, Remohí J, et al. Vascular endotelial growth factor receptor-2 activation induces vascular permeability in hyperstimulation rats, and this effect is prevented by receptor blockade. Endocrinology 2002; 143: 4339-48.
-
(2002)
Endocrinology
, vol.143
, pp. 4339-4348
-
-
Gómez, R.1
Simón, C.2
Remohí, J.3
-
12
-
-
79958719365
-
Differential regulation of vascular mediators by hCG versus GnRH agonists
-
Cerrillo M, Pacheco A, Rodriguez S, et al. Differential regulation of vascular mediators by hCG versus GnRH agonists. Hum Reprod 2010; 25(supl 1): i249.
-
(2010)
Hum Reprod
, vol.25
, Issue.SUPPL. 1
-
-
Cerrillo, M.1
Pacheco, A.2
Rodriguez, S.3
-
13
-
-
0017816022
-
Ovarian hyperstimulation syndrome: A current survey
-
Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978; 30: 255-68.
-
(1978)
Fertil Steril
, vol.30
, pp. 255-268
-
-
Schenker, J.G.1
Weinstein, D.2
-
14
-
-
0024334512
-
Ovarian hyperstimulation syndrome: An update review
-
Golan A, Ron-el R, Herman A, et al. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989; 44: 430-40.
-
(1989)
Obstet Gynecol Surv
, vol.44
, pp. 430-440
-
-
Golan, A.1
Ron-El, R.2
Herman, A.3
-
15
-
-
0038689325
-
Ovarian hyperstimulation syndrome: Classifications and critical analysis of preventive measures
-
Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003; 9: 275-89.
-
(2003)
Hum Reprod Update
, vol.9
, pp. 275-289
-
-
Aboulghar, M.A.1
Mansour, R.T.2
-
16
-
-
85026152880
-
Bilateral pleural effusion and ascites in the ovarian hyperstimulation syndrome
-
Calvo-Romero JM, Lima-Rodríguez EM. Bilateral pleural effusion and ascites in the ovarian hyperstimulation syndrome. Eur J Emerg Med 2004; 11: 348-50.
-
(2004)
Eur J Emerg Med
, vol.11
, pp. 348-350
-
-
Calvo-Romero, J.M.1
Lima-Rodríguez, E.M.2
-
17
-
-
0031659728
-
Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome
-
Fábregues F, Balasch J, Manau D, et al. Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Hum Reprod 1998; 13: 2406-10.
-
(1998)
Hum Reprod
, vol.13
, pp. 2406-2410
-
-
Fábregues, F.1
Balasch, J.2
Manau, D.3
-
19
-
-
33750210002
-
Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis
-
Kolibianakis EM, Collins J, Tarlatzis BC, et al. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006; 12: 657-71.
-
(2006)
Hum Reprod Update
, vol.12
, pp. 657-671
-
-
Kolibianakis, E.M.1
Collins, J.2
Tarlatzis, B.C.3
-
20
-
-
0025146431
-
Use of gonadotropinreleasing hormone agonist to trigger follicular maturation for in vitro fertilization
-
Gonen Y, Balakier H, Powell W, et al. Use of gonadotropinreleasing hormone agonist to trigger follicular maturation for in vitro fertilization. Clin Endocrinol Metab 1990; 71: 918-22.
-
(1990)
Clin Endocrinol Metab
, vol.71
, pp. 918-922
-
-
Gonen, Y.1
Balakier, H.2
Powell, W.3
-
21
-
-
0025883825
-
Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist
-
Itskovitz J, Boldes R, Levron J, et al. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 1991; 56: 213-20.
-
(1991)
Fertil Steril
, vol.56
, pp. 213-220
-
-
Itskovitz, J.1
Boldes, R.2
Levron, J.3
-
23
-
-
0026766599
-
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in vitro fertilization
-
Segal S, Casper RF. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in vitro fertilization. Fertil Steril 1992; 57: 1254-8.
-
(1992)
Fertil Steril
, vol.57
, pp. 1254-1258
-
-
Segal, S.1
Casper, R.F.2
-
24
-
-
0141606263
-
No supplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in vitro fertilization patients after ovarian stimulation with recombinant follicle stimulating hormone and GnRH antagonist cotreatment
-
Beckers NG, Macklon NS, Eijkemans MJ, et al. No supplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in vitro fertilization patients after ovarian stimulation with recombinant follicle stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003; 88: 4186-92.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 4186-4192
-
-
Beckers, N.G.1
Macklon, N.S.2
Eijkemans, M.J.3
-
25
-
-
18044400218
-
Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin
-
Parneix I, Emperaire JC, Ruffie A, et al. Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin Gynecol Obstet Fertil. 2001; 29: 100-5.
-
(2001)
Gynecol Obstet Fertil
, vol.29
, pp. 100-105
-
-
Parneix, I.1
Emperaire, J.C.2
Ruffie, A.3
-
26
-
-
59349114171
-
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: Findings of a large retrospective cohort study
-
Bodri D, Guillén J, Galindo A, et al. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 2009; 91: 365-71.
-
(2009)
Fertil Steril
, vol.91
, pp. 365-371
-
-
Bodri, D.1
Guillén, J.2
Galindo, A.3
-
27
-
-
63249084659
-
No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles
-
Hernandez ER, Gomez-Palomares JL, Ricciarelli E. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril 2009; 91: 1358-61.
-
(2009)
Fertil Steril
, vol.91
, pp. 1358-1361
-
-
Hernandez, E.R.1
Gomez-Palomares, J.L.2
Ricciarelli, E.3
-
28
-
-
63249114848
-
Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: A rationale for OHSS reduction
-
Cerrillo M, Rodríguez S, Mayoral M, et al. Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction. Fertil Steril 2009; 91: 1526-8.
-
(2009)
Fertil Steril
, vol.91
, pp. 1526-1528
-
-
Cerrillo, M.1
Rodríguez, S.2
Mayoral, M.3
-
29
-
-
27144499019
-
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists
-
Kolibianakis EM, Schultze-Mosgau A, Schroer A, et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 2005; 20: 2887-92.
-
(2005)
Hum Reprod
, vol.20
, pp. 2887-2892
-
-
Kolibianakis, E.M.1
Schultze-Mosgau, A.2
Schroer, A.3
-
30
-
-
20444394425
-
GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: A prospective randomized study
-
Humaidan P, Bredkjaer HE, Bungum L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005; 20: 1213-20.
-
(2005)
Hum Reprod
, vol.20
, pp. 1213-1220
-
-
Humaidan, P.1
Bredkjaer, H.E.2
Bungum, L.3
-
31
-
-
33751073732
-
GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS
-
Engmann L, Siano L, Schmidt D, et al. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS. Reprod Biomed Online 2006; 13: 639-44.
-
(2006)
Reprod Biomed Online
, vol.13
, pp. 639-644
-
-
Engmann, L.1
Siano, L.2
Schmidt, D.3
-
32
-
-
77649211847
-
Cycles triggered with GnRH agonist: Exploring low-dose HCG for luteal support
-
Castillo JC, Dolz M, Bienvenido E, et al. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support. Reprod Biomed Online 2010; 20: 175-81.
-
(2010)
Reprod Biomed Online
, vol.20
, pp. 175-181
-
-
Castillo, J.C.1
Dolz, M.2
Bienvenido, E.3
-
33
-
-
33751230189
-
Triggering ovulation with gonadotropin-releasing hormone agonist does not compromise embryo implantation rates
-
Acevedo B, Gómez-Palomares JL, Ricciarelli MD, et al. Triggering ovulation with gonadotropin-releasing hormone agonist does not compromise embryo implantation rates. Fertil Steril 2006; 86: 1682-7.
-
(2006)
Fertil Steril
, vol.86
, pp. 1682-1687
-
-
Acevedo, B.1
Gómez-Palomares, J.L.2
Ricciarelli, M.D.3
-
34
-
-
34347209929
-
Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles
-
Saphiro B, Daneshmand S, Garner F, et al. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles Fertil Steril 2006; 88: 237-9.
-
(2006)
Fertil Steril
, vol.88
, pp. 237-239
-
-
Saphiro, B.1
Daneshmand, S.2
Garner, F.3
-
35
-
-
84894403337
-
A full year OHSS-free: The ultimaté protocol for egg donors
-
Álvarez A, Matey S, Ruiz M, et al. A full year OHSS-free: the ultimaté protocol for egg donors. Hum Reprod 2009; 24 (suppl 21): i20.
-
(2009)
Hum Reprod
, vol.24
, Issue.SUPPL. 21
-
-
Álvarez, A.1
Matey, S.2
Ruiz, M.3
-
36
-
-
70449397316
-
GnRH agonist versus recombinant HCG in an oocyte donation programme: A randomised, prospective, controlled, assessor-blind study
-
Melo M, Busso CE, Bellver J, et al. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomised, prospective, controlled, assessor-blind study. Reprod Biomed Online 2009; 19: 486-92.
-
(2009)
Reprod Biomed Online
, vol.19
, pp. 486-492
-
-
Melo, M.1
Busso, C.E.2
Bellver, J.3
-
37
-
-
63249084659
-
No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles
-
Hernandez ER, Gomez-Palomares JL, Ricciarelli E. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril 2009; 91: 1358-61.
-
(2009)
Fertil Steril
, vol.91
, pp. 1358-1361
-
-
Hernandez, E.R.1
Gomez-Palomares, J.L.2
Ricciarelli, E.3
-
38
-
-
77957807220
-
GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation
-
Oktay K, Türkçüolu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online 2010; 20: 783-8.
-
(2010)
Reprod Biomed Online
, vol.20
, pp. 783-788
-
-
Oktay, K.1
Türkçüolu, I.2
Rodriguez-Wallberg, K.A.3
-
39
-
-
84859161529
-
Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment
-
Domingo J, Guillén V, Ayllón Y, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril 2012; 97: 930-4.
-
(2012)
Fertil Steril
, vol.97
, pp. 930-934
-
-
Domingo, J.1
Guillén, V.2
Ayllón, Y.3
-
40
-
-
32644447350
-
GnRH Agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: A systematic review and meta-analysis
-
Griesinger G, Diedrich K, Devroey P, et al. GnRH Agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006; 12: 159-68.
-
(2006)
Hum Reprod Update
, vol.12
, pp. 159-168
-
-
Griesinger, G.1
Diedrich, K.2
Devroey, P.3
-
41
-
-
33747059580
-
Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: A pilot study
-
Humaidan P, Bungum L, Bungum M, et al. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006; 13: 173-8.
-
(2006)
Reprod Biomed Online
, vol.13
, pp. 173-178
-
-
Humaidan, P.1
Bungum, L.2
Bungum, M.3
-
42
-
-
75749138165
-
1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: A prospective, randomised, controlled study
-
Humaidan P, Ejdrup Bredkjaer H, et al. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomised, controlled study. Fertil Steril 2010; 93: 847-54.
-
(2010)
Fertil Steril
, vol.93
, pp. 847-854
-
-
Humaidan, P.1
Ejdrup Bredkjaer, H.2
-
43
-
-
79951945981
-
A novel method of luteal supplementation with recombinant LH, when a GnRHAgonist is used instead of HCG for ovulation triggering. A randomized prospective proof of concept study
-
Papanikolaou EG, Verpoest W, Fatemi H, et al. A novel method of luteal supplementation with recombinant LH, when a GnRHAgonist is used instead of HCG for ovulation triggering. A randomized prospective proof of concept study. Fertil Steril 2011; 3: 1174-7
-
(2011)
Fertil Steril
, vol.3
, pp. 1174-1177
-
-
Papanikolaou, E.G.1
Verpoest, W.2
Fatemi, H.3
-
44
-
-
33645847254
-
Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: A prospective randomized trial
-
Babayof R, Margalioth EJ, Huleihel M, et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum Reprod 2006; 21: 1260-5
-
(2006)
Hum Reprod
, vol.21
, pp. 1260-1265
-
-
Babayof, R.1
Margalioth, E.J.2
Huleihel, M.3
-
45
-
-
80052902532
-
An OHSS-Free Clinic by segmentation of IVF treatment
-
Devroey P, Polyzos N, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod 2011; 26: 2593-7.
-
(2011)
Hum Reprod
, vol.26
, pp. 2593-2597
-
-
Devroey, P.1
Polyzos, N.2
Blockeel, C.3
-
46
-
-
24644455926
-
Highly efficient vitrification method for cryopreservation of human oocytes
-
Kuwayama M, Vajta G, Kato O, et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005; 11: 300-8.
-
(2005)
Reprod Biomed Online
, vol.11
, pp. 300-308
-
-
Kuwayama, M.1
Vajta, G.2
Kato, O.3
-
47
-
-
44349124425
-
Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by Cryotop method
-
Cobo A, Kuwayama M, Pérez S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by Cryotop method. Fertil Steril 2007; 89: 1657-64.
-
(2007)
Fertil Steril
, vol.89
, pp. 1657-1664
-
-
Cobo, A.1
Kuwayama, M.2
Pérez, S.3
-
48
-
-
77955962803
-
Use of cryo-banked oocytes in an ovum donation programme: A prospective, randomized, controlled, clinical trial
-
Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod 2010; 25: 2239-46.
-
(2010)
Hum Reprod
, vol.25
, pp. 2239-2246
-
-
Cobo, A.1
Meseguer, M.2
Remohí, J.3
Pellicer, A.4
-
49
-
-
72849148916
-
Embryo development of fresh "versus" vitrified metaphase IIoocytes after ICSI: A prospective randomizaed sibling-oocyte study
-
Rienzi L, Romano S, Albricci L, et al. Embryo development of fresh "versus" vitrified metaphase IIoocytes after ICSI: a prospective randomizaed sibling-oocyte study. Hum Reprod 2010; 25: 66-73.
-
(2010)
Hum Reprod
, vol.25
, pp. 66-73
-
-
Rienzi, L.1
Romano, S.2
Albricci, L.3
-
50
-
-
79951947677
-
Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: A new strategy to avoid ovarian hyperstimulation syndrome
-
Herrero L, Pareja S, Losada C, Cobo A, Pellicer A, García-Velasco JA. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome. Fertil Steril 2011; 93: 1137-40.
-
(2011)
Fertil Steril
, vol.93
, pp. 1137-1140
-
-
Herrero, L.1
Pareja, S.2
Losada, C.3
Cobo, A.4
Pellicer, A.5
García-Velasco, J.A.6
-
51
-
-
84857789379
-
Agonist trigger: What is the best approach? Agonist trigger with vitrification of oocytes or embryos
-
García-Velasco JA. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil Steril 2012; 97: 527-8.
-
(2012)
Fertil Steril
, vol.97
, pp. 527-528
-
-
García-Velasco, J.A.1
-
52
-
-
54149102502
-
A randomised controlled study of human Day 3 embryo cryopreservation by slow freezing or vitrification: Vitrification is associated with higher survival, metabolism and blastocyst formation
-
Balaban B, Urman B, Ata B, et al. A randomised controlled study of human Day 3 embryo cryopreservation by slow freezing or vitrification: vitrification is associated with higher survival, metabolism and blastocyst formation. Hum Reprod 2008; 23: 1976-82.
-
(2008)
Hum Reprod
, vol.23
, pp. 1976-1982
-
-
Balaban, B.1
Urman, B.2
Ata, B.3
-
53
-
-
79960647582
-
Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: A prospective randomized trial comparing fresh and frozen-thawed embryo transfer in high responders
-
Shapiro B, Daneshmand S, Garner F, Aguirre M, Hudson C, Thomas S. evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in high responders. Fertil Steril 2011; 96: 516-8.
-
(2011)
Fertil Steril
, vol.96
, pp. 516-518
-
-
Shapiro, B.1
Daneshmand, S.2
Garner, F.3
Aguirre, M.4
Hudson, C.5
Thomas, S.6
-
54
-
-
84894404366
-
Endometrial Receptivity Arrays (ERA) with different luteal support protocols after triggering final oocyte maturation with GnRH agonist
-
Bermejo A, Cerrillo M, Ortega I, et al. Endometrial Receptivity Arrays (ERA) with different luteal support protocols after triggering final oocyte maturation with GnRH agonist. Hum Reprod 2012; 27(suppl 2): ii93-ii95.
-
(2012)
Hum Reprod
, vol.27
, Issue.SUPPL. 2
-
-
Bermejo, A.1
Cerrillo, M.2
Ortega, I.3
-
55
-
-
78650418973
-
A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature
-
Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature. Fertil Steril 2011; 95: 50-60.
-
(2011)
Fertil Steril
, vol.95
, pp. 50-60
-
-
Díaz-Gimeno, P.1
Horcajadas, J.A.2
Martínez-Conejero, J.A.3
-
56
-
-
84867835285
-
Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in rFSH stimulated and GnRH antagonist co-treated IVF cycles
-
Humaidan P, Van Vaerenbergh I, Bourgain C, et al. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in rFSH stimulated and GnRH antagonist co-treated IVF cycles Hum Reprod 2012; 27: 3259-72.
-
(2012)
Hum Reprod
, vol.27
, pp. 3259-3272
-
-
Humaidan, P.1
van Vaerenbergh, I.2
Bourgain, C.3
|